快速可视化非黑色素瘤皮肤癌:淬灭活性探针成像研究
本研究应用淬灭活性探针GB119于68例非黑色素瘤皮肤癌(NMSC)切除标本,验证其区分癌组织与正常外观皮肤的价值。结果显示,探针可区分基底细胞癌和鳞状细胞癌与正常皮肤,总体估计灵敏度0.989(95%CI 0.940-1.00),特异度0.894(95%CI 0.769-0.965),并能准确界定NMSC周边切缘。
要点
- GB119探针局部应用可快速区分NMSC与正常皮肤,灵敏度0.989、特异度0.894。
- 探针激活可准确界定NMSC周边切缘,与常规HE病理比较一致。
- 研究仅纳入减瘤切除标本,最终切缘的敏感度和特异度需进一步验证。
核心结论
- 淬灭活性探针GB119局部应用可快速可视化区分NMSC与正常外观皮肤,并准确界定周边切缘。
研究设计与样本
- 研究将淬灭活性探针GB119应用于68例非黑色素瘤皮肤癌(NMSC)切除标本,以苏木精-伊红(HE)确认的癌组织与正常外观皮肤组织进行比较验证。
主要发现
- 探针局部应用区分基底细胞癌和鳞状细胞癌与正常外观皮肤,总体估计灵敏度为0.989(95%CI 0.940-1.00),特异度为0.894(95%CI 0.769-0.965)。
- 与常规HE病理相比,探针激活可准确界定NMSC的周边切缘。
关键数值与推荐
- 总体估计灵敏度0.989(95%CI 0.940-1.00),特异度0.894(95%CI 0.769-0.965),用于区分基底细胞癌和鳞状细胞癌与正常外观皮肤。
临床怎么用
- 该技术有望在非Mohs手术中快速评估切除完整性,减少再切除和复发,但需进一步研究验证最终切缘的准确性。
局限性
- 本研究仅检查了NMSC减瘤切除标本,未评估最终NMSC切除切缘的敏感度和特异度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mohs micrographic surgery examines all margins of the resected sample and has a 99% cure rate. However, many nonmelanoma skin cancers (NMSCs) are not readily amenable to Mohs micrographic surgery. This defines an unmet clinical need to assess the completeness of non-Mohs micrographic surgery resections during surgery to prevent re-excision/recurrence. OBJECTIVE: We sought to examine the utility of quenched activity-based probe imaging to discriminate cancerous versus normal-appearing skin tissue. METHODS: The quenched activity-based probe GB119 was applied to NMSC excised from 68 patients. We validated activation of the probe for hematoxylin-eosin-confirmed cancerous tissue versus normal-appearing skin tissue. RESULTS: Topical application of the probe differentiated basal cell carcinoma and squamous cell carcinoma from normal-appearing skin with overall estimated sensitivity and specificity of 0.989 (95% confidence interval 0.940-1.00) and 0.894 (95% confidence interval 0.769-0.965), respectively. Probe activation accurately defined peripheral margins of NMSC as compared with conventional hematoxylin-eosin-based pathology. LIMITATIONS: This study only examined NMSC debulking excision specimens. The sensitivity and specificity for this approach using final NMSC excision margins will be clinically important. CONCLUSIONS: These findings merit further studies to determine whether quenched activity-based probe technology may enable cost-effective increased cure rates for patients with NMSC by reducing re-excision and recurrence rates with a rapid and easily interpretable technological advance.
引用
- Walker E, Mann M, Honda K, et al. Rapid visualization of nonmelanoma skin cancer. J Am Acad Dermatol. 2016. PMID: 27876303. doi:10.1016/j.jaad.2016.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。